moatshark My

All holdings

DaVita

DVA

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
1
In their latest 13F (Q3 2026)
See who
Value held
$6.4bn
Combined value at quarter end
Last quarter
0 bought
1 sold or trimmed
Price at Q2 ’26 end
$222.48
+44.8% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+18.3%Q3 ’24
-8.8%Q4 ’24
+2.3%Q1 ’25
-6.9%Q2 ’25
-6.7%Q3 ’25
-14.5%Q4 ’25
+35.3%Q1 ’26
+44.8%Q2 ’26
Q3 ’24: +18.3%; Q4 ’24: -8.8%; Q1 ’25: +2.3%; Q2 ’25: -6.9%; Q3 ’25: -6.7%; Q4 ’25: -14.5%; Q1 ’26: +35.3%; Q2 ’26: +44.8%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

1Q4 ’23
1Q1 ’24
1Q2 ’24
1Q3 ’24
1Q4 ’24
1Q1 ’25
1Q2 ’25
1Q3 ’25
1Q4 ’25
1Q1 ’26
1Q2 ’26
0Q3 ’26
Q4 ’23: 1; Q1 ’24: 1; Q2 ’24: 1; Q3 ’24: 1; Q4 ’24: 1; Q1 ’25: 1; Q2 ’25: 1; Q3 ’25: 1; Q4 ’25: 1; Q1 ’26: 1; Q2 ’26: 1; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes DaVita.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding DaVita
Berkshire Hathaway2.1%$6.4bn$6.4bnTrimmed -4.1%53 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of DaVita
Bought or soldFiling
31 Jul 2026Berkshire Hathaway INC10% owner▼ Sold182,980$199.55$36.5mForm 4

About the company

Sector
Health care · Services-Misc Health & Allied Services, Nec
Incorporated in
Delaware
Financial year ends
31 December
Shares outstanding
64m at 31 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

2013
2015
$11bn2017
$11bn2019
$12bn2021
$12bn2023
$14bn2025
2013: not held; 2014: not held; 2015: not held; 2016: $11bn; 2017: $11bn; 2018: $11bn; 2019: $11bn; 2020: $12bn; 2021: $12bn; 2022: $12bn; 2023: $12bn; 2024: $13bn; 2025: $14bn
DaVita revenue and net income by year
YearRevenueNet income
2025$14bn$1.1bn
2024$13bn$1.3bn
2023$12bn$957m
2022$12bn$782m
2021$12bn$1.2bn
2020$12bn$774m
2019$11bn$811m
2018$11bn$159m
2017$11bn$664m
2016$11bn$880m
2015–$270m
2014–$723m
2013–$633m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.